The Patent Finder

RFS Pharma, LLC

Also on record
Records under this name other than patents RFS Pharma, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to RFS Pharma, LLC

PatentTitleStatus Expires Confidence
US 8,415,321Nucleoside Derivatives for Treatment of Caliciviridae Infections, Including Norovirus Infections
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,181,227Potent and Selective Inhibitors of Hepatitis C Virus
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,809,616Pyrimidine Nucleosides and Their Monophosphate Prodrugs for Treatment of Viral Infections and Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,815,8293'-Azido Purine Nucleotide Prodrugs for Treatment of Viral Infections
Formerly held
Lapsed on the fee record
Ended Aug 26, 2026 · High confidence
Lapsed on the fee recordEnded Aug 26, 2026High confidence
US 8,895,5312′-fluoronucleoside phosphonates as antiviral agents
Formerly held
Lapsed on the fee record
Ended Nov 25, 2022 · From the USPTO record
Lapsed on the fee recordEnded Nov 25, 2022From the USPTO record
US 8,859,595Potent and Selective Inhibitors of Hepatitis C Virus
Formerly held
Lapsed on the fee record
Ended Oct 14, 2022 · High confidence
Lapsed on the fee recordEnded Oct 14, 2022High confidence
US 8,609,627Purine Nucleoside Monophosphate Prodrugs for Treatment of Cancer and Viral Infections
Formerly held
Lapsed on the fee record
Ended Dec 17, 2021 · High confidence
Lapsed on the fee recordEnded Dec 17, 2021High confidence
US 9,173,893Purine Nucleoside Monophosphate Prodrugs for Treatment of Cancer and Viral Infections
Formerly held
Lapsed on the fee record
Ended Nov 3, 2019 · High confidence
Lapsed on the fee recordEnded Nov 3, 2019High confidence
US 9,040,479HCV NS3 protease inhibitors
Formerly held
Lapsed on the fee record
Ended May 26, 2019 · From the USPTO record
Lapsed on the fee recordEnded May 26, 2019From the USPTO record
US 8,729,014Specific HCV NS3 protease inhibitors
Formerly held
Lapsed on the fee record
Ended May 20, 2018 · From the USPTO record
Lapsed on the fee recordEnded May 20, 2018From the USPTO record
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited